FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> EDC | Medidata

Ludwig Cancer Institute picks Medidata Rave

Free Newsletter

FierceBiotech IT updates senior biotech, pharma, and IT leaders on how IT advances are shaping clinical trials and clinical research. Get your weekly briefing on clinical trial design and management systems, adaptive trials, eClinical trials, and more. Sign up today!



Tools

The nonprofit Ludwig Institute for Cancer Research Ltd (LICR) has chosen Medidata Rave as its electronic data capture and clinical data management solution. The Institute's clinical trials integrate laboratory and clinical research.

In the EDC selection process, LICR searched for a system that could meet the needs of complex oncology studies while linking its international research sites. The institute required a system that was intuitive and configurable, allowing staff members to build and manage their own studies, according to a Medidata announcement. It also focused on the ability to conduct frequent mid-study changes without taking the system off-line or disrupting site data input availability in any way.

With approximately 800 scientific, clinical and support staff across 10 research branches located in Australia, Brazil, Europe and the U.S., LICR conducts clinical research to translate its discoveries into applications for human benefits.

- here's the announcement

Related Articles:
Medidata lands Kitasato University as Rave implementer
Cancer center evaluates EDC solutions, picks Medidata Rave
Safety reporting tool leads Medidata to strong 2009


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotechIT Email Newsletter:

More stories about EDC   Medidata